$9.10
5.21% day before yesterday
Nasdaq, Aug 01, 10:00 pm CET
ISIN
US67113Y1082
Symbol
NUWE

Nuwellis Inc Stock price

$9.10
-0.61 6.33% 1M
-41.72 82.09% 6M
-37.52 80.48% YTD
-106.82 92.15% 1Y
-82,707.80 99.99% 3Y
-4,409,990.90 100.00% 5Y
-110,020,679,990.90 100.00% 10Y
-444,379,823,990.90 100.00% 20Y
Nasdaq, Closing price Fri, Aug 01 2025
-0.50 5.21%

Key metrics

Basic
Market capitalization
$1.0m
Enterprise Value
$-1.5m
Net debt
positive
Cash
$2.6m
Shares outstanding
100.0k
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.1 | 0.1
EV/Sales
negative | negative
EV/FCF
0.2
P/B
0.3
Financial Health
Equity Ratio
66.2%
Return on Equity
-162.7%
ROCE
-197.2%
ROIC
-319.5%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$8.8m | $9.3m
EBITDA
$-8.1m | -
EBIT
$-8.4m | $-8.6m
Net Income
$-9.9m | $-200.0k
Free Cash Flow
$-9.3m
Growth (TTM | estimate)
Revenue
-1.2% | 6.5%
EBITDA
50.0% | -
EBIT
49.2% | 21.7%
Net Income
50.6% | 98.1%
Free Cash Flow
37.5%
Margin (TTM | estimate)
Gross
63.2%
EBITDA
-92.1% | -
EBIT
-95.6%
Net
-112.1% | -2.1%
Free Cash Flow
-105.8%
More
EPS
$-94.6
FCF per Share
$-93.0
Short interest
1.4%
Employees
38
Rev per Employee
$230.0k
Show more

Is Nuwellis Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,028 stocks worldwide.

Nuwellis Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Nuwellis Inc forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Nuwellis Inc forecast:

Buy
86%
Hold
14%

Financial data from Nuwellis Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
8.79 8.79
1% 1%
100%
- Direct Costs 3.24 3.24
15% 15%
37%
5.55 5.55
9% 9%
63%
- Selling and Administrative Expenses 12 12
24% 24%
141%
- Research and Development Expense 2.43 2.43
54% 54%
28%
-8.09 -8.09
50% 50%
-92%
- Depreciation and Amortization 0.31 0.31
11% 11%
4%
EBIT (Operating Income) EBIT -8.40 -8.40
49% 49%
-96%
Net Profit -9.85 -9.85
51% 51%
-112%

In millions USD.

Don't miss a Thing! We will send you all news about Nuwellis Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Nuwellis Inc Stock News

Neutral
GlobeNewsWire
11 days ago
MINNEAPOLIS, July 23, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc., today announced that John Erb, President and Chief Executive Officer of Nuwellis, participated in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference. For the event, Mr.
Neutral
GlobeNewsWire
11 days ago
MINNEAPOLIS, July 23, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on fluid management solutions for patients with fluid overload, today announced that it has regained compliance with the Nasdaq Capital Market's minimum bid price requirement under Listing Rule 5550(a)(2). On July 22, 2025, the Company received formal notice from Nasdaq stating tha...
Neutral
GlobeNewsWire
12 days ago
MINNEAPOLIS, July 22, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical technology company focused on transforming the lives of people with fluid overload, today announced that it will release financial results for the second quarter 2025 on August 12, 2025. Nuwellis will host a conference call and webcast at 9:00 AM ET to discuss its financial results and provi...
More Nuwellis Inc News

Company Profile

Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.

Head office United States
CEO John Erb
Employees 38
Founded 1999
Website www.nuwellis.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today